GI & Hepatology

Medication Burden Climbs After 75 in Patients With Steatotic Liver Disease

Medication Burden Climbs After 75 in Patients With Steatotic Liver Disease

Sonia Reyes
Specialty Medicine, GI & Hepatology, Managed Care, Value Based Care | Jul 22, 2026
An NHANES analysis found polypharmacy in older adults with MASLD rises sharply after age 75, raising deprescribing and goal-concordant care questions for payers.
Load More
Only Healthcare Today Covering Clinical Healthcare, Access and Cost

Only Healthcare Today
Covering Clinical Healthcare, Access and Cost

1 Hewitt Square, Suite 139
East Northport, NY 11731

Who We Are


About Us Editorial Policy Contributors & Partners

Connect


Contact Us Work With Us Advertising Terms of Use Privacy Policy